Decision: Favourable

Study Title:

A PHASE IIIB, MULTICENTER, RANDOMIZED, VISUAL ASSESSOR-MASKED STUDY OF THE EFFECTIVENESS AND SAFETY OF A 36-WEEK REFILL REGIMEN FOR THE PORT DELIVERY SYSTEM WITH RANIBIZUMAB VS AFLIBERCEPT TREAT & EXTEND IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DE

  • NREC Code:

    22-NREC-CT-020

  • Decision:

    Favourable

  • Study Type:

    CT application

  • Principal Investigator:

    Mr Mark Cahill

  • PI Institution:

    Royal Victoria Eye and Ear Hospital

  • Sponsor:

    Roche

Scroll to Top
Skip to content